Price
$105.28
Decreased by -0.59%
Dollar Volume (20D)
642.74 M
ADR%
1.7
Earnings Report Date (estimate)
Jul 18, 24
Shares Float
1.72 B
Shares Outstanding
1.74 B
Shares Short
14.48 M
Market Cap.
189.5 B
Beta
0.74
Price / Earnings
33.4
20D Range
104.25 113.46
50D Range
104.25 121.04
200D Range
88.8 121.04
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Jan 24, 24 1.19
Increased by +15.53%
1.19
Oct 18, 23 1.14
Decreased by -0.87%
1.1
Increased by +3.64%
Jul 20, 23 1.08
Decreased by -24.48%
1.05
Increased by +2.86%
Apr 19, 23 1.03
Decreased by -40.46%
0.99
Increased by +4.04%
Jan 25, 23 1.03
Decreased by -21.97%
0.92
Increased by +11.96%
Oct 19, 22 1.15
Decreased by -17.86%
0.94
Increased by +22.34%
Jul 20, 22 1.43
Increased by +22.22%
1.13
Increased by +26.55%
Apr 20, 22 1.73
Increased by +31.06%
1.47
Increased by +17.69%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 10.24 B
Increased by +1.49%
1.59 B
Increased by +54.31%
Increased by +15.56%
Increased by +52.05%
Sep 30, 23 10.14 B
Decreased by -2.56%
1.44 B
Increased by +0.07%
Increased by +14.16%
Increased by +2.7%
Jun 30, 23 9.98 B
Decreased by -11.36%
1.38 B
Decreased by -31.86%
Increased by +13.78%
Decreased by -23.13%
Mar 31, 23 9.75 B
Decreased by -18.06%
1.32 B
Decreased by -46.14%
Increased by +13.52%
Decreased by -34.27%
Dec 31, 22 10.09 B
Decreased by -12.01%
1.03 B
Decreased by -48.06%
Increased by +10.24%
Decreased by -40.98%
Sep 30, 22 10.41 B
Decreased by -4.74%
1.44 B
Decreased by -31.67%
Increased by +13.78%
Decreased by -28.27%
Jun 30, 22 11.26 B
Increased by +10.11%
2.02 B
Increased by +69.72%
Increased by +17.93%
Increased by +54.13%
Mar 31, 22 11.89 B
Increased by +13.76%
2.45 B
Increased by +36.48%
Increased by +20.57%
Increased by +19.97%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.